What triggers cancer
Pro Research Analysisby 
Searched over 200M research papers
Triggers of Cancer: Key Insights from Recent Research
Inflammation and Cancer Development
Chronic Inflammation as a Major Trigger
Chronic inflammation is a significant contributor to cancer development, accounting for approximately 25% of cancer cases . Inflammatory processes can induce genetic and epigenetic changes, such as point mutations in tumor suppressor genes and DNA methylation, which disrupt normal cellular homeostasis and lead to cancer. Inflammation-related cancers often exhibit mutagenic DNA lesions, such as 8-oxodG and 8-nitroguanine, which are found in tissues affected by infections and pro-inflammatory factors.
Tumor Microenvironment and Inflammation
The tumor microenvironment (TME) plays a crucial role in cancer progression. Cancer cells, along with stromal and inflammatory cells, interact to create an inflammatory TME that promotes tumor initiation, growth, and metastasis. This environment is highly dynamic, with cells continuously changing their characteristics, which complicates the treatment and management of cancer.
Infection-Induced Inflammation
Infections by certain pathogens, such as Helicobacter pylori, human papillomavirus (HPV), and Epstein-Barr virus, are well-documented triggers of chronic inflammation that can lead to cancer . For instance, H. pylori infection is strongly linked to gastric cancer due to its ability to cause lifelong inflammation, which induces cell proliferation and the production of mutagenic free radicals.
Genetic Mutations and Cancer
Role of Genomic Instability
Genomic instability and mutations are fundamental to cancer development. These genetic alterations affect cell proliferation, apoptosis, and immune responses, and are increasingly recognized as drivers of metastasis. Mutations can trigger and accelerate the migration and invasion of cancer cells, which are critical steps in cancer progression.
Epigenetic Changes
Epigenetic alterations, such as DNA methylation and microRNA dysregulation, are also pivotal in carcinogenesis, particularly in inflammation-related cancers. These changes can serve as biomarkers for early detection and prevention of cancer, as demonstrated in studies on Epstein-Barr virus-related nasopharyngeal carcinoma.
Surgery and Cancer Recurrence
Perioperative Inflammation
Surgical intervention, while essential for cancer treatment, can paradoxically trigger cancer recurrence. The perioperative period is marked by increased risk for the growth of micrometastatic disease and the formation of new metastatic foci. Surgery induces local and systemic inflammatory responses, which can enhance the migration and invasion of residual cancer cells.
Microbiome and Cancer
Microbial Influence on Inflammation
The human microbiome, particularly in the cervicovaginal region, can influence cancer development through inflammation. Certain microbes can trigger inflammatory responses that contribute to the development of cervical cancer. Understanding the relationship between microbes and cancer can lead to new therapeutic approaches, such as probiotic therapy and immunotherapy.
Conclusion
Cancer is triggered by a complex interplay of factors, with chronic inflammation, genetic mutations, and microbial infections playing significant roles. Understanding these triggers is crucial for developing effective prevention and treatment strategies. Ongoing research continues to uncover the intricate mechanisms behind cancer initiation and progression, offering hope for improved therapeutic interventions in the future.
Sources and full results
Most relevant research papers on this topic